SEI Investments’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.7M Buy
220,759
+79,334
+56% +$9.97M 0.03% 556
2025
Q1
$15.6M Sell
141,425
-8,999
-6% -$995K 0.02% 785
2024
Q4
$20.5M Sell
150,424
-4,695
-3% -$641K 0.03% 657
2024
Q3
$17.9M Buy
155,119
+27,103
+21% +$3.12M 0.02% 724
2024
Q2
$17.6M Buy
128,016
+41,347
+48% +$5.69M 0.03% 656
2024
Q1
$12M Sell
86,669
-29,289
-25% -$4.04M 0.02% 833
2023
Q4
$15.3M Buy
115,958
+25,416
+28% +$3.35M 0.02% 690
2023
Q3
$10.2M Sell
90,542
-47
-0.1% -$5.29K 0.02% 850
2023
Q2
$8.54M Buy
90,589
+6,417
+8% +$605K 0.01% 954
2023
Q1
$8.52M Sell
84,172
-28,311
-25% -$2.87M 0.02% 937
2022
Q4
$13.4M Buy
112,483
+2,270
+2% +$271K 0.03% 612
2022
Q3
$11.7M Buy
110,213
+51,512
+88% +$5.47M 0.03% 695
2022
Q2
$5.66M Buy
58,701
+1,879
+3% +$181K 0.01% 1031
2022
Q1
$5.27M Sell
56,822
-3,647
-6% -$338K 0.01% 1081
2021
Q4
$5.11M Buy
60,469
+2,695
+5% +$228K 0.01% 1129
2021
Q3
$5.48M Buy
57,774
+88
+0.2% +$8.35K 0.01% 1031
2021
Q2
$5.43M Sell
57,686
-2,569
-4% -$242K 0.01% 1033
2021
Q1
$5.73M Sell
60,255
-25,788
-30% -$2.45M 0.01% 956
2020
Q4
$8.13M Buy
86,043
+18,826
+28% +$1.78M 0.02% 738
2020
Q3
$6.37M Sell
67,217
-5,856
-8% -$555K 0.02% 752
2020
Q2
$8.72M Buy
73,073
+3,104
+4% +$370K 0.03% 603
2020
Q1
$6.05M Sell
69,969
-6,055
-8% -$523K 0.02% 668
2019
Q4
$8.17M Sell
76,024
-1,950
-3% -$210K 0.02% 670
2019
Q3
$7.03M Buy
77,974
+7,864
+11% +$709K 0.02% 765
2019
Q2
$5.92M Buy
70,110
+17,089
+32% +$1.44M 0.02% 854
2019
Q1
$4.67M Sell
53,021
-58,204
-52% -$5.13M 0.02% 942
2018
Q4
$13.4M Buy
111,225
+1,706
+2% +$205K 0.05% 423
2018
Q3
$13.5M Buy
109,519
+4,541
+4% +$558K 0.05% 408
2018
Q2
$10.3M Sell
104,978
-7,199
-6% -$707K 0.04% 567
2018
Q1
$9.3M Sell
112,177
-21,127
-16% -$1.75M 0.04% 544
2017
Q4
$10.3M Buy
133,304
+15,594
+13% +$1.21M 0.04% 598
2017
Q3
$7.21M Buy
117,710
+11,321
+11% +$694K 0.03% 729
2017
Q2
$4.89M Buy
106,389
+27,330
+35% +$1.26M 0.02% 853
2017
Q1
$3.42M Buy
79,059
+9,363
+13% +$405K 0.02% 950
2016
Q4
$2.7M Buy
69,696
+3,797
+6% +$147K 0.01% 1038
2016
Q3
$3.34M Buy
65,899
+5,097
+8% +$258K 0.02% 879
2016
Q2
$2.76M Buy
60,802
+50,358
+482% +$2.29M 0.02% 888
2016
Q1
$413K Sell
10,444
-2,665
-20% -$105K ﹤0.01% 1354
2015
Q4
$741K Sell
13,109
-30,252
-70% -$1.71M ﹤0.01% 1274
2015
Q3
$1.73M Buy
43,361
+35,633
+461% +$1.42M 0.02% 850
2015
Q2
$369K Buy
7,728
+6,344
+458% +$303K ﹤0.01% 1266
2015
Q1
$55K Buy
+1,384
New +$55K ﹤0.01% 1667